Compare ETFs
Fees, size, distributions, currency exposure and holdings overlap for two to four funds, side by side.
Side by side
| Measure | FXHFirst Trust Health Care AlphaDEX | VOOVanguard S&P 500 ETF |
|---|---|---|
| Market | USNYSE Arca | USNYSE Arca |
| Issuer | First Trust | Vanguard |
| Asset class | Equity · US | Equity · US |
| Expense ratio | 0.61%Net expense ratio, filed 28 Nov 2025 | 0.03%Expense ratio, filed 28 Apr 2026 |
| Net assets | $1.0BAs of 31 Jul 2026 | $1.7TAs of 30 Jun 2026 |
| Holdings | 75As of 31 Jul 2026 | 520As of 30 Jun 2026 |
| 12-month distribution yield | 0.55% | 1.05% |
| Distributions | Quarterly$0.7360 in 12 months | Quarterly$7.4280 in 12 months |
| Last price | $135.0520 Oct 2026, 20:00 UTC | $706.8020 Oct 2026, 20:00 UTC |
Holdings overlap
Weighted overlap is the sum, over the securities both funds hold, of the smaller of the two weights. 0% means no shared holdings; 100% means identical portfolios.
| Fund | FXH | VOO |
|---|---|---|
| FXH | Same fund | 6.6% |
| VOO | 6.6% | Same fund |
FXH and VOO
- Weighted overlap
- 6.6%
- Holdings in common
- 44
- FXH holdings also in VOO
- 60.3% by count
- VOO holdings also in FXH
- 8.7% by count
| Holding | Weight in FXH | Weight in VOO | Overlap | Matched by |
|---|---|---|---|---|
| ELI LILLY & COMPANYELI LILLY & COMPANY COM US5324571083 | 1.62% | 1.47% | 1.47% | ISIN |
| ABBVIE INCABBVIE INC COM US00287Y1091 | 0.84% | 0.69% | 0.69% | ISIN |
| MERCK & COMPANY INCMERCK & COMPANY INC COM US58933Y1055 | 0.43% | 0.49% | 0.43% | ISIN |
| JOHNSON & JOHNSONJOHNSON & JOHNSON COM US4781601046 | 0.43% | 0.95% | 0.43% | ISIN |
| AMGEN INCAMGEN INC COM US0311621009 | 0.45% | 0.30% | 0.30% | ISIN |
| THERMO FISHER SCIENTIFIC INCTHERMO FISHER SCIENTIFIC INC COM US8835561023 | 0.97% | 0.29% | 0.29% | ISIN |
| ABBOTT LABORATORIESABBOTT LABORATORIES COM US0028241000 | 0.98% | 0.25% | 0.25% | ISIN |
| GILEAD SCIENCES INCGILEAD SCIENCES INC COM US3755581036 | 1.40% | 0.24% | 0.24% | ISIN |
| PFIZER INCPFIZER INC COM US7170811035 | 2.35% | 0.21% | 0.21% | ISIN |
| VERTEX PHARMACEUTICALS INCVERTEX PHARMACEUTICALS INC COM US92532F1003 | 0.81% | 0.20% | 0.20% | ISIN |
How overlap is measured
Each fund's latest public Form N-PORT report lists its positions with the percent of net assets each one makes up. For every security both funds hold, the smaller of its two weights is counted, and those are added up. If fund A holds a stock at 6% and fund B at 4%, that stock adds 4 percentage points.
Securities are matched by ISIN first, then by CUSIP (a US or Canadian ISIN contains the CUSIP), and only as a last resort by issuer name, for non-debt holdings where one fund gives no identifier. Repeated lines of the same security in one fund are added together, and each security is matched once.
Cash funds, repurchase agreements, derivative contracts and short positions are left out because their reported value is not comparable exposure. For funds with more than 2,000 positions only the largest 2,000 are stored, so the result is a lower bound and the possible extra is shown. Reports can be for different month ends, and funds trade between reports.
The count-based shares show how many of one fund's holdings the other also holds, which can be high even when overlap by weight is low. Read more in where the ETF data comes from.
Currency exposure
| Currency | FXH | VOO |
|---|---|---|
| US dollar (USD) | 100.0% | 100.1% |